Editorial on management of diabetes mellitus with coronary artery disease

Archives of Medical Science

Volumn 7, Issue 6, 2011, Pages 928-930

  Aronow, Wilbert S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; PRAVASTATIN;

BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EDITORIAL; EXERCISE; HEALTH PROGRAM; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HYPERTENSION; HYPOGLYCEMIA; PERCUTANEOUS CORONARY INTERVENTION; SMOKING CESSATION; STROKE; UNSTABLE ANGINA PECTORIS;

EID: 84855390795     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/AOMS.2011.26601     Document Type: Editorial

References (20)

1. Athyros VG, Gossios TD, Tziomalos K, et al. Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment? Arch Med Sci 2011; 7: 1066-74.
2. Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European society of Hypertension. J Am Coll Cardiol 2011; 57: 2037-114.
3. Bangalore S, Qin J, Sloan S, et al. What is the optimal blood pressure in patients after acute coronary syndromes? Relationship of blood pressure and cardiovascular events in the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation 2010; 122: 2142-51.
4. Cooper-DeHoff RM, Gong Y, Handberg EM, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 2010; 304: 61-8.
5. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-39. (Pubitemid 38924592)
6. Aronow WS, Ahn C, Gutstein H. Reduction of new coronary events and of new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol ≥125 mg/dl treated with statins. J Gerontol Med Sci 2002; 57A: M747-50. (Pubitemid 35340556)
7. Ravipati G, Aronow WS, Kumbar S, et al. Patients with diabetes mellitus with ischemic stroke have a higher hemoglobin A1c level and a higher serum low-density lipoprotein cholesterol level than diabetics without ischemic stroke. Arch Med Sci 2009; 5: 391-3.
8. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-59.
9. Smith SC Jr, Allen J, Blair SN, et al. ACC/AHA guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113: 2363-72. (Pubitemid 43947981)
10. Aronow WS, Ahn C. Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and diabetes mellitus. Am J Cardiol 2001; 87: 780-1. (Pubitemid 32209099)
11. Aronow WS, Ahn C, Kronzon I. Reductions of incidences of new coronary events and of congestive heart failure by beta blockers alone, by angiotensin-convering enzyme inhibitors alone, and by beta blockers plus angiotensin-converting enzyme inhibitors in older persons with prior myocardial infarction and asymptomatic left ventricular systolic dysfunction. Am J Cardiol 2001; 88: 1298-300. (Pubitemid 33132100)
12. Lai HM, Aronow WS, Mercando AD, et al. The impact of statin therapy on long-term cardiovascular outcomes in an outpatient cardiology practice. Med Sci Monit 2011; 17: CR683-6.
13. Mercando AD, Lai HM, Aronow WS, et al. Reduction in atherosclerotic events through use of aggressive risk factor reduction medications: a retrospective study in an outpatient cardiology practice. Arch Med Sci 2012; 8 (in press).
14. Aronow WS, Frishman WH. Angina in the elderly. In: Aronow WS, Fleg JL, Rich MW (eds): Cardiovascular disease in the elderly. Fourth edition, New York city, Informa Healthcare, 2008, pp 269-92.
15. Maron DJ, Boden WE, Spertus JA, et al. Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug evaluation) trial. J Am Coll Cardiol 2011; 58: 131-7.
16. The BARI 2 D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009; 360: 2503-15.
17. Dagenais GR, Lu J, Faxon DP, et al. Effect of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease. Circulation 2011; 123: 1492-500.
18. BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007; 49: 1600-6.
19. Kushner FG, Hand M, Smith SC, Jr, et al. 2009 focused updastes: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA /SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009; 120: 2271-306.
20. Wright RS, Anderson JL, Adams CD, et al. 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST- elevation myocardial infarction (updating the 2007 guideline). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011; 57: 1920-59.